|
|
Volumn 55, Issue 14, 2010, Pages 1503-1505
|
|
Improvement of Left Ventricular Dysfunction and of Survival Prognosis of Dilated Cardiomyopathy by Administration of Calcium Sensitizer SCH00013 in a Mouse Model
a
a
a
a
a
a
a
a
a
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
6 [1 [2 (4 CYANOPHENYL) 2 HYDROXYETHYL] 1,2,5,6 TETRAHYDRO 4 PYRIDYL] 4,5 DIHYDRO 3(2H) PYRIDAZINONE;
ANGIOTENSIN RECEPTOR ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM SENSITIZER;
CARDIOTONIC AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HISTIDINE;
PROLINE;
APOPTOSIS;
BODY WEIGHT;
CONGESTIVE CARDIOMYOPATHY;
DISEASE COURSE;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG INHIBITION;
GENE EXPRESSION;
GENE MUTATION;
HEART FAILURE;
HEART LEFT VENTRICLE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART LEFT VENTRICLE FAILURE;
HEART LEFT VENTRICLE FUNCTION;
HEART MUSCLE;
HEART MUSCLE CELL;
HEART MUSCLE CONTRACTILITY;
HEART MUSCLE FIBROSIS;
HEART VENTRICLE REMODELING;
LETTER;
LIFE EXPECTANCY;
LONG TERM CARE;
MAXIMUM PLASMA CONCENTRATION;
MORTALITY;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROGNOSIS;
RECEPTOR UPREGULATION;
RISK FACTOR;
SIGNAL TRANSDUCTION;
SURVIVAL RATE;
SURVIVAL TIME;
TIME TO MAXIMUM PLASMA CONCENTRATION;
TREATMENT DURATION;
TREATMENT OUTCOME;
ANIMALS;
CARDIOMYOPATHY, DILATED;
DIHYDROPYRIDINES;
MICE;
PYRIDAZINES;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
VENTRICULAR DYSFUNCTION, LEFT;
|
|
EID: 77949886788
PISSN: 07351097
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jacc.2009.10.065 Document Type: Letter |
|
Times cited : (17)
|
|
References (5)
|
